Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
Not enough history yet.
US$ billions, as reported in each year's annual results.
Operating income as a share of revenue. US dollars at each year's exchange rate.
| Measure | GenVec✕ GNVC |
|---|---|
| Profile | |
| Country | 🇺🇸 USA |
| Sector | Healthcare |
| Industry | Biotechnology |
| Founded | — |
| Size | |
| Revenue | $1 M |
| Net income | $-6 M |
| Employees | |
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | GenVec |
|---|---|
| 2014 | -42.1%SEC |
| 2013 | -279.6%SEC |
| 2012 | -150.8%SEC |
| 2011 | -42.2%SEC |
| 2010 | -76.6%SEC |
| 2009 | -129.9%SEC |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| 15 |
| Altman Z-score zone | — |
|---|
| Data as of | Market cap — |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.